Evidence map›Paper›PMID 30158470›Full record

ArticleJournal of fungi (Basel, Switzerland)2018

Itraconazole, Voriconazole, and Posaconazole CLSI MIC Distributions for Wild-Type and Azole-Resistant

Jochem B Buil, Ferry Hagen, Anuradha Chowdhary, Paul E Verweij, Jacques F Meis

Open access · goldAbstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Activity of Azole and Non-Azole Substances AgainstInternational journal of molecular sciences · 2025
    Article
  8. Review
  9. Evaluation of the Activity of Triazoles Against Non-Open forum infectious diseases · 2024
    Article
  10. Article
  11. Article
  12. Trends in the activity of mold-active azole agents againstJournal of clinical microbiology · 2024
    Article
  13. Article
  14. The Transcriptome Response to Azole Compounds inJournal of fungi (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Citizen Science Surveillance of Triazole-ResistantApplied and environmental microbiology · 2022
    Article
  19. Review
  20. Point Mutation or Overexpression of Aspergillus fumigatusAntimicrobial agents and chemotherapy · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Jochem B BuilDepartment of Medical Microbiology, Radboud University Medical Center, 6525 Nijmegen, The Netherlands. jochem.buil@radboudumc.nl.
Ferry HagenDepartment of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, 6532 Nijmegen, The Netherlands. f.hagen@gmail.com.ORCID 0000-0002-5622-1916
Anuradha ChowdharyDepartment of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi 110021, India. chowdhary.anuradha@gmail.com.ORCID 0000-0002-2028-7462
Paul E VerweijDepartment of Medical Microbiology, Radboud University Medical Center, 6525 Nijmegen, The Netherlands. paul.verweij@radboudumc.nl.
Jacques F MeisCenter of Expertise in Mycology Radboudumc/CWZ, 6525 Nijmegen, The Netherlands. jacques.meis@gmail.com.ORCID 0000-0003-3253-6080
Radboud University Nijmegen · NLUniversity of Delhi · INWesterdijk Fungal Biodiversity Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Azole resistance in

Indexed as

aspergillosisazole resistanceCLSI broth microdilutioncyp51AECV

Identifiers

PMID30158470
PMCPMC6162657
OpenAlexW2889408191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.